Qsam Biosciences Executives
Qsam Biosciences employs about 4 people. The company is managed by 5 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 0.8 employees per reported executive. Analysis of Qsam Biosciences' management performance can provide insight into the firm performance.
| Dr MA Chairman CoFounder Chairman |
Qsam |
Qsam Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (2.3809) % which means that it has lost $2.3809 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (33.7707) %, meaning that it created substantial loss on money invested by shareholders. Qsam Biosciences' management efficiency ratios could be used to measure how well Qsam Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Qsam Biosciences Workforce Comparison
Qsam Biosciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,050. Qsam Biosciences adds roughly 4.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Qsam Biosciences Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Qsam Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Qsam Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Qsam Biosciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
King Adam over six months ago Disposition of tradable shares by King Adam of Qsam Biosciences at 9.62 subject to Rule 16b-3 | ||
Link Jr Charles J over a year ago Qsam Biosciences exotic insider transaction detected | ||
Christopher Nelson over a year ago Conversion by Christopher Nelson of 8683 shares of Qsam Biosciences | ||
Piazza C Richard over a year ago Qsam Biosciences exotic insider transaction detected | ||
King Adam over a year ago Acquisition by King Adam of 20910 shares of Qsam Biosciences subject to Rule 16b-3 | ||
Link Jr Charles J over a year ago Acquisition by Link Jr Charles J of 10455 shares of Qsam Biosciences subject to Rule 16b-3 |
Qsam Biosciences Notable Stakeholders
A Qsam Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Qsam Biosciences often face trade-offs trying to please all of them. Qsam Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Qsam Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dr MA | CoFounder Chairman | Profile | |
| Adam CPA | Chief Officer | Profile | |
| Namrata Chand | Vice Operations | Profile | |
| Douglas Baum | CEO CoFounder | Profile | |
| Christopher Nelson | General Development | Profile |
Qsam Biosciences Workforce Analysis
Traditionally, organizations such as Qsam Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Qsam Biosciences within its industry.Qsam Biosciences Manpower Efficiency
Return on Qsam Biosciences Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 878.6K | |
| Working Capital Per Employee | 168.1K | |
| Working Capital Per Executive | 134.5K |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |